229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
115.79%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-16.67%
Negative yoy D&A while VUZI is 22.92%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
225.00%
Deferred tax of 225.00% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-100.00%
Both cut yoy SBC, with VUZI at -72.80%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
115.15%
Slight usage while VUZI is negative at -19.64%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-160.53%
Both yoy AR lines negative, with VUZI at -73.35%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-700.00%
Negative yoy inventory while VUZI is 80.56%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
768.29%
A yoy AP increase while VUZI is negative at -192.98%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-1400.00%
Negative yoy usage while VUZI is 352.14%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
140.00%
Well above VUZI's 100.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
812.50%
Some CFO growth while VUZI is negative at -38.64%. John Neff would note a short-term liquidity lead over the competitor.
-26.09%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
24.55%
Purchases growth of 24.55% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-44.73%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.00%
We reduce yoy other investing while VUZI is 6.90%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-343.24%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
46.67%
Lower share issuance yoy vs. VUZI's 124.06%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.